EpiCept Corporation (EPCT.ST)

EPCT.ST on Stockholm Stock Exchange

15.60SEK
9 Feb 2010
Price Change (% chg)

-1.00kr (-6.02%)
Prev Close
15.60kr
Open
--
Day's High
15.90kr
Day's Low
15.40kr
Volume
536,363
Avg. Vol
778,453
52-wk High
23.70kr
52-wk Low
12.60kr

EPCT.ST

Chart for EPCT.ST

About

EpiCept Corporation (EpiCept) is a specialty pharmaceutical company focused on the development of pharmaceutical products for the treatment of cancer and pain. The Company’s cancer portfolio includes Crinobulin, or EPC2407, a small molecule vascular disruption agent (VDA), and apoptosis inducer for the treatment of patients with... (more)

Overall

Beta: 0.89
Market Cap (Mil.): kr94.67
Shares Outstanding (Mil.): 44.03
Annual Dividend: 0.00
Yield (%): NA

Financials

  EPCT.ST Industry Sector
P/E (TTM): -- 6.43 3.76
EPS (TTM): 23.46 -- --
ROI: -7,486.63 5.95 2.30
ROE: -- 8.98 2.82
view overview for:

Competitors

  Price Change
Pfizer Inc. (PFE.N) $17.88 +0.04
Endo Pharmaceuticals (ENDP.OQ) $19.63 +0.10

  Earnings  vs    Estimates

view overview for: